INVITAE CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 USD | -94.44% |
|
-66.67% | -99.92% |
| Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
| Apr. 25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 480.7 | 825.3 | 1,557 | 7,388 | 3,457 | 451.8 |
| Enterprise Value (EV) 1 | 454.6 | 777.2 | 1,484 | 7,484 | 4,135 | 1,656 |
| P/E ratio | -3.42 x | -5.71 x | -6.06 x | -9.34 x | -8.5 x | -0.14 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 7.05 x | 5.59 x | 7.18 x | 26.4 x | 7.51 x | 0.88 x |
| EV / Revenue | 6.66 x | 5.26 x | 6.84 x | 26.8 x | 8.98 x | 3.21 x |
| EV / EBITDA | -4.16 x | -7.41 x | -8.28 x | -19.5 x | -5.96 x | -2.86 x |
| EV / FCF | -9.96 x | -12.1 x | -62.6 x | -572 x | -13.7 x | -7.01 x |
| FCF Yield | -10% | -8.3% | -1.6% | -0.17% | -7.32% | -14.3% |
| Price to Book | 4 x | 5.16 x | 4.2 x | 3.93 x | 1.17 x | 4.49 x |
| Nbr of stocks (in thousands) | 52,945 | 74,617 | 96,522 | 176,700 | 226,371 | 242,896 |
| Reference price 2 | 9.080 | 11.06 | 16.13 | 41.81 | 15.27 | 1.860 |
| Announcement Date | 3/6/18 | 2/28/19 | 3/2/20 | 2/26/21 | 3/1/22 | 2/28/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 68.22 | 147.7 | 216.8 | 279.6 | 460.4 | 516.3 |
| EBITDA 1 | -109.4 | -104.9 | -179.3 | -384 | -694.1 | -578.3 |
| EBIT 1 | -117.6 | -118.4 | -195.5 | -423 | -774.5 | -714.2 |
| Operating Margin | -172.4% | -80.17% | -90.18% | -151.3% | -168.22% | -138.34% |
| Earnings before Tax (EBT) 1 | -125.2 | -132.2 | -260.4 | -714.3 | -415.9 | -3,151 |
| Net income 1 | -123.4 | -129.4 | -242 | -602.2 | -379 | -3,106 |
| Net margin | -180.85% | -87.58% | -111.6% | -215.37% | -82.31% | -601.64% |
| EPS 2 | -2.653 | -1.938 | -2.663 | -4.474 | -1.797 | -13.18 |
| Free Cash Flow 1 | -45.63 | -64.49 | -23.7 | -13.09 | -302.9 | -236.1 |
| FCF margin | -66.88% | -43.66% | -10.93% | -4.68% | -65.77% | -45.73% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/6/18 | 2/28/19 | 3/2/20 | 2/26/21 | 3/1/22 | 2/28/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 116.3 | 114.4 | 126.1 | 123.7 | 136.6 | 133.5 | 122.5 | 117.4 | 120.5 | 121.2 |
| EBITDA 1 | -115.5 | -159.4 | -146 | -136.7 | -108.2 | -48.29 | -39.71 | -41.54 | -63.98 | -26.78 |
| EBIT 1 | -134.1 | -181 | -169.6 | -163.8 | -145.4 | -88.77 | -77.06 | -76.5 | -97.68 | -58.52 |
| Operating Margin | -115.34% | -158.2% | -134.51% | -132.41% | -106.41% | -66.48% | -62.93% | -65.18% | -81.04% | -48.27% |
| Earnings before Tax (EBT) 1 | -145.5 | -204 | -212.8 | -216.8 | -2,527 | -302.2 | -105.2 | -193.1 | -207.4 | -948.3 |
| Net income 1 | -129 | -198.2 | -205.1 | -181.9 | -2,523 | -301.2 | -99.82 | -192.2 | -206.5 | -942.1 |
| Net margin | -110.88% | -173.24% | -162.64% | -147.03% | -1,847.04% | -225.52% | -81.51% | -163.76% | -171.33% | -777.05% |
| EPS 2 | -0.6400 | -0.9100 | -0.9000 | -0.8000 | -10.87 | -1.270 | -0.4100 | -0.7700 | -0.7800 | -3.420 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/3/21 | 11/8/21 | 2/24/22 | 5/3/22 | 8/9/22 | 11/8/22 | 2/28/23 | 5/9/23 | 8/8/23 | 11/8/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 96.2 | 679 | 1,204 |
| Net Cash position 1 | 26.1 | 48.1 | 73 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -0.2504 x | -0.9779 x | -2.082 x |
| Free Cash Flow 1 | -45.6 | -64.5 | -23.7 | -13.1 | -303 | -236 |
| ROE (net income / shareholders' equity) | -112% | -91.2% | -89.4% | -51.1% | -15.3% | -202% |
| ROA (Net income/ Total Assets) | -43% | -30% | -23% | -12.6% | -11.6% | -13% |
| Assets 1 | 286.8 | 431.8 | 1,054 | 4,797 | 3,269 | 23,916 |
| Book Value Per Share 2 | 2.270 | 2.140 | 3.840 | 10.60 | 13.10 | 0.4100 |
| Cash Flow per Share 2 | 0.2200 | 1.490 | 1.530 | 0.6700 | 4.050 | 1.050 |
| Capex 1 | 6.68 | 5.97 | 20 | 22.9 | 54.7 | 53.3 |
| Capex / Sales | 9.78% | 4.04% | 9.25% | 8.18% | 11.88% | 10.33% |
| Announcement Date | 3/6/18 | 2/28/19 | 3/2/20 | 2/26/21 | 3/1/22 | 2/28/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -99.92% | 143K | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 377M |
- Stock Market
- Equities
- NVTA.Q Stock
- Financials Invitae Corporation
